Our website now includes a page which will contain guidance and information related to the COVID-19 vaccine for patients with haemoglobinopathies. We'll keep it updated in line with new developments. https://t.co/LB2GLwBHwG #COVID19Vaccination#COVIDVaccine#teamhaem
Big day tomorrow for all our excellent clinicians and experts in haematology and #SickleCell and of course their patients. Awareness and advocacy are vital. #SickleCellAwarenessDay
Third to present is Prof John Porter, Consultant Haematologist at University College London Hospital and lead for the joint red cell service with the @WhitHealth@HCC_UCLH on clinical trials
Prof Porter is also the Vice Chair of the @PanelNational for #thalassaemia!
#uktsconf
Incredibly proud of Giselle Padmore-Payne ,Senior CNS who dedicates her all to improve the lives of those with #thalassaemia & #SCD
HRH "Whenever I have the great pleasure of meeting Roald Dahl Specialist Nurses,I'm always struck by kindness, resourcefulness & boundless energy"
Cancer patients may need their second dose of COVID-19 vaccine in three weeks, not 12 weeks, British researchers reported last week. https://t.co/5iVllWe6Xv
Our friends at West London HCC have produced an informative FAQs guidance sheet on the #CovidVaccine. Find it along with other guidance on COVID-19 vaccines in haemoglobinopathy patients on our website. Thanks @docesr and colleagues. https://t.co/LB2GLwBHwG
Interested in learning more about 'transfusion challenges in haemoglobinopathy'? You can view the video of this event hosted by @STSTNetwork & the papers given by @redcellsara & Dr Stella T. Chou of the Children's Hospital of Philadelphia via our website: https://t.co/fqiDXPKWKi
The Sickle Cell Disease Association of America Medical and Research Advisory Committee (MARAC) has issued a statement regarding the temporary suspension of bluebird clinical trials of LentiGlobin Gene Therapy for Sickle Cell Disease. Read via our website: https://t.co/OPlArtSedA
We have recently published information on COVID-19 in haemoglobinopathy & rare anaemia patients, dealing with case numbers, hospitalisations & clinical outcomes. It can be found with other resources on COVID-19 on our website https://t.co/joDR6fTemF
Our NHP clinicians are at the forefront of treating patients with rare anaemias and helping them to live healthy and fulfilling lives. Long may it continue. #RareDiseaseDay2021
Asking twice can make all the difference.
Here are some tips on how to start conversations about mental health with your friends, family or colleagues.
#TimeToChange#MentalHealth ⬇️
Asking twice can make all the difference.
Here are some tips on how to start conversations about mental health with your friends, family or colleagues.
#TimeToChange#MentalHealth ⬇️
Thanks to all those who attended yesterday's monthly MDT for February, some excellent and thought-provoking discussions on pregnancy in #sicklecell patients, management of extramedullary haematopoiesis, and other issues.
Next MDT is Monday 29th March.
Really interesting sequence of talks with experts in genomics and blood transfusion. A must for people interested in blood transfusion #sicklecelldisease#thalassaemia@PanelNational
BSH is looking for a clinical scientist to represent haematology at the ACS. The BSH representative is nominated as an ACS Director/Trustee and is considered the lead for the haematology within the ACS. To apply go to our website. https://t.co/pyY8NRnjv1
Please circulate among South London-based patients, families, and clinicians, and encourage them to take part in this important initiative. It's a brief survey, will only take 5 minutes to complete. #sicklecell
"HCC is looking forward to the new Grafton Way Building, with our fantastic art installation, by Dryden Goodwin, giving us an amazing presence and featuring some of HCC’s heroes."
Stephen Rowley
HCC Chair
Senior Matron Haematology @uclh